The complement-fixing activity of crude lipid extracts of 10 Mycoplasma species was compared with that of whole organism antigens employing immune rabbit serum. Five species (M. pneumoniae, M. neurolyticum, M. granularum, M. laidlawii, and M. fermentans) showed serological activity, whereas the remaining five species (M. 
Studies of the antigenic structure of mycoplasmata have thus far revealed only a few characteristics of their antigens. The information available indicates that the organisms in the order Mycoplasmatales are surprisingly heterogeneous, not only in serology (11) but also in chemical class of the major antigens. The major antigen of Mycoplasma pneumoniae as measured by complement fixation against either rabbit or human convalescent sera is found in the lipid fraction (13) . The serologically active lipids are glyceroglycolipids which contain both glucose and galactose (2) and probably represent three or more serological specificities (16) . On the other hand, the major antigen of M. mycoides var. mycoides appears to be polysaccharide although serologically active glycolipids are present (14) . Whereas M. fermentans contains specific serologically active lipids as its major complementfixing antigen (10) , another glycolytic species with a similar guanine plus cytosine content (% GC), M. pulmonis, does not contain serologically active lipids, but the major complementfixing antigen appears to contain protein components (4, 10) . A survery of some nonglycolytic, arginine-utilizing species has shown that these species [M. hominis, M. pharyngis (orale I), M. orale II, and M. arthritidis] did not contain major lipid antigens but that their major antigens are heat-labile (10) . Hollingdale and Lemcke (9) have shown that M. hominis contains a serologically active lipid as a minor antigen which was specific in the sense that it reacted with homologous rabbit antiserum, but it did not react with antisera to M. salivariunm, M. orale I, or M. arthritidis. M. laidlawii contains serologically active glucolipids (15) . [A new genus, Acholeplasma, has recently been proposed for M. laidlawii and M. granularum (5) ].
This study is an investigation of the occurrence and specificity of serologically active lipids in 10 glycolytic species in the order Mycoplasmatales. Some of these data were presented in a preliminary communication (Abstr., Xth Int. Congr. Microbiol., 1970, p. 92).
MATERIALS AND METHODS
Antigens and antisera. The source, strains, and clonal status of the Mycoplasma species employed (Table 1) have been described previously (11) . The serological test antigens, immunogens. and rabbit antisera were prepared as also described previously (11) . Serological test antigens were propagated in soy-peptone-fresh yeast dialysate medium (10) sup- plemented with 10% agamma horse serum, whereas immunogens were cultivated in the same broth sup-149 (Table 2) ; however, antigen titers were markedly different (Table 3 ). It appears likely that the glycolipids of M. pneumoniae contain multiple serological specificities (16) . Although preliminary evidence (data not shown) suggests that M. neurolyticum has several glyco- (11) . Cross-reactions were not observed when both organisms were cross-tested by disc inhibition on agar by using the method of Clyde (3) .
Human serum antibody studies. The antibody response of humans known to be infected with M. pnewnoniae as evidenced by isolation of the organism (6) was tested with lipids from three species: M. pnewnoniae, M. neurolyticum, and M. granularum. Table 4 shows representative data for six pairs of acute and convalescent sera of the 20 tested which showed fourfold antibody rise to M. pneumoniae. Essentially the same antibody response attained with M. pnewnoniae lipids was observed with M. neurolyticum. This close correlation is shown in more detail in Fig. 1 (16) . Similarly, diglucosyl diglyceride prepared from Streptococcus MG has been shown to cross-react with the diglucosyl diglyceride of M. laidlawii (15) .
Substantial evidence exists to support the concept that lipid antigens are the determinants for both the metabolic-inhibition test (17, 19) and the complement-mediated killing reaction of M. pneumoniae (7) . Preliminary results suggest that M. neuroly.icum antibody will readily kill M. pneumoniae in the presence of complement (J. L. Gale, personal conminunication). However, the reciprocal experiment has not yet been carried out. No cross-reactivity between the two species was observed by disc inhibition on agar. This fact suggests that lipid is not the determinant for this reaction. However, it is possible that a different antibody (either antibody against a different configuration of the lipids on the membrane surface or antibody of a different immunoglobulin class) against lipids might play a role in inhibition on agar. Rabbit antibodies which inhibit growth of M. pneumoniae on agar are produced later than antibodies measured by complement fixation with lipid antigen (12) . However, it would seem rather difficult for lipid to be the determinant of growth inhibition on agar for both M. pneunoniae and M. neurolyticum.
The cross-reaction between M. pnewutoniae and M. neurolyticum was much more evident when lipids were compared than when whole organism antigens were tested. In a previous study only two of four M. pneumoniae antisera reacted with intact M. neurolyticum whole organism antigen, and neither of the two M. neurolyticuml antisera reacted with intact M. pneumoniae (11) . One reason for this is that lipid was found to be a relatively minor antigen for M. neurolyticum, whereas it is the major antigen for M. pneumoniae. It is also possible that the glycolipids may be organized differently in the intact membrane or that the relative concentrations of the various glycolipids differ between the two organisms. In this regard, it has been demonstrated that when M. pneumoniae glycolipids are reaggregated with delipidized membranes of M. laidlawiii and the reaggregated complex is injected into rabbits, the antisera produced will have substantial antibody against M. pneumoniae as measured by metabolicinhibition testing and complement fixation against lipid antigen (19) . The cross-reaction of M. neurolyticum with M. pneunoniae appears to be a natural model of this phenomenon since the cross-reaction appears based only on common lipid antigen(s).
The possession of lipid antigens does not appear to be the sine qua non for organisms of the order Mycoplasmatales. Thus, the organisms in the Mycoplasmatales are not only markedly heterogeneous physiologically (1), in deoxyribonucleic acid base composition (21) , protein patterns on polyacrylamide electrophoresis (18) , and comparative serology (11) but also they are heterogeneous in chemical class of major antigen.
The presence of common lipid antigens between M. pneumoniae and other mycoplasmic and bacterial species has significance for the interpretation of serological testing of human sera. Fourfold antibody rises between acute and convalescent sera from pneumonia patients correlate well with isolation of M. pneunoniae (8) . However, the presence of cross-reacting or common lipids in other organisms suggests the need for caution in interpreting the results of serological surveys of human sera. Since lipid is necessarily the deter-minant for complement-fixing antibody measured against lipid antigen and lipid appears to be the determinant for antibody measured by both metabolic-inhibition and the complement-mediated killing reaction, caution is advised in interpreting the presence of antibody as necessarily indicating prior infection with M. pneumoniae when using these serological tests. Other organisms could provide the antigenic stimulus for these antibodies. A good natural example of this is the frequent occurrence of both antilipid complement-fixing antibody and complement-mediated killing antibody to M. pnewnoniae in normal rabbits (7, 13) . Rabbits are not known to be infected with either M. pneumoniae or M. neurolyticum. Whether antibody induced in humans by other organisms which contain immunologically similar glyceroglycolipids would protect against infection is a provocative question.
The cross-reaction between M. pneunoniae and M. neurolyticum appears to be fortuitous and should not be taken to imply taxonomic relationships between these two species. M. neurolyticwn appears to belong to that loosely related group of Mycoplasma species which have low % GC ranging from 25 to 28% (see Table 1 for the other species in this group). The low % GC group showed no relationship to M. pneumoniae when compared by double immunodiffusion tests where 6 to 11 lines were seen in the homologous system (11) . Therefore, M. pneumoniae and M. neurolyticwn appear to be species far more distinct phylogenetically than is indicated by their present classification since organisms in the same genus or family would be expected to contain a number of common antigens.
The presence of fortuitously cross-reacting agents does raise the possibility of serological diagnosis of infections due to uncultivatable mycoplasmata. For example, M. pneumoniae infections could have been diagnosed with great specificity as early as 1940 by using the lipids of M. neurolyticuni, an organism which was already known at that time (20) . Although this discovery did not occur, another organism, Streptococcus MG, was found to have some serological utility for diagnosis of that portion of atypical pneumonia which was ultimately determined to be caused by M. pneumloniae.
